Case report reveals long-term follow-up for drug-induced liver injury in childhood acute lymphoblastic leukemia patients post-chemotherapy.
This case highlights the need for long-term clinical, biochemical, and radiological follow-up of ALL patients with recurrent DILI, to monitor for progression to chronic DlLI both during and post-chemotherapy.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: